rfk jr glp-1 Jr. on coverage for medication, HHS cuts Can RFK Jr. Limit Ozempic

Description

Weight loss is known to trigger compensatory biology: Increased appetite signaling Reduced resting energy expenditure Heightened food reward sensitivity Stopping GLP-1 therapy at peak dose, without tapering and without reinforcing lifestyle strategies at the exact moment hunger returns, does not allow lifestyle behaviors to take over. Emerging real-world data and obesity physiology suggest a different, more clinically relevant path: Gradual dose reduction rather than abrupt cessation Continued, structured dietary and exercise support Active monitoring during the high-risk post-cessation period We still need randomized trials designed specifically to test tapering and lifestyle-anchored maintenance strategies

This is for the man or woman who takes gut health seriously who understands that the microbiome is the foundation of metabolic health, appetite regulation and digestive wellbeing and wants the most scientifically advanced probiotic formula available featuring the breakthrough strain that standard probiotic brands cannot deliver